addmedica


addmedica Home Page
addmedica
Chairman's foreword
Team
Unmet medical needs and products
Job offers
Business opportunities
European network
Business development
Products
SIKLOS® (Hydroxycarbamide)
LUMIDERM® 6000
HYALOMATRIX® PA
PERFADEX®
STEEN Solution™
Comments and questions?
A memorial to Jean-Michel

Chairman's foreword

HomeContact-usWebsite map
addmedica is a  fast growing, privately owned, European company focused on developing and marketing medical products for:
  • rare diseases
  • unmet medical needs in developed and emerging countries
  • serious conditions
addmedica is dedicated to providing high medical value to physicians, patients, and managed care organizations, by developing, registering and marketing a wide range of medical products in several rare and debilitating diseases. Our areas of interest comprise :
-       wound healing, tissue growth, cell culture
-       organ transplant, tissue replacement
-       genetic diseases, drug or substitute therapy, cell or gene therapy

The company is proud to offer its current range of products in the fields of lung transplantation, wound healing and deep burn care. The first drug indicated in the Sickle Cell Disease in Europe is also approved and already launched in several European countries.
 
addmedica is constantly looking for new opportunities and partnerships, to develop and commercialize products with high medical demand. 

As a result of its know-how, its commitment and its positioning, addmedica is ready to become a leading firm for the provision of medical products and innovative techniques for rare diseases with the best quality of services.

 
François Anger
Chairman


© ADDMEDICA - adding value for health
Legal Information